165 related articles for article (PubMed ID: 19628039)
1. Tacrolimus causes a blockage of protein secretion which reinforces its immunosuppressive activity and also explains some of its toxic side-effects.
Rauch MC; San Martín A; Ojeda D; Quezada C; Salas M; Cárcamo JG; Yañez AJ; Slebe JC; Claude A
Transpl Immunol; 2009 Dec; 22(1-2):72-81. PubMed ID: 19628039
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cytokine production and cytokine-stimulated T-cell activation by FK506 (tacrolimus)1.
Almawi WY; Assi JW; Chudzik DM; Jaoude MM; Rieder MJ
Cell Transplant; 2001; 10(7):615-23. PubMed ID: 11714196
[TBL] [Abstract][Full Text] [Related]
3. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells.
Redmon JB; Olson LK; Armstrong MB; Greene MJ; Robertson RP
J Clin Invest; 1996 Dec; 98(12):2786-93. PubMed ID: 8981925
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cytokine production by plant sterols in stimulated human Jurkat T cells.
Aherne SA; O'Brien NM
Mol Nutr Food Res; 2008 Jun; 52(6):664-73. PubMed ID: 18465778
[TBL] [Abstract][Full Text] [Related]
5. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
Sawada S; Suzuki G; Kawase Y; Takaku F
J Immunol; 1987 Sep; 139(6):1797-803. PubMed ID: 2442255
[TBL] [Abstract][Full Text] [Related]
6. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.
Tocci MJ; Matkovich DA; Collier KA; Kwok P; Dumont F; Lin S; Degudicibus S; Siekierka JJ; Chin J; Hutchinson NI
J Immunol; 1989 Jul; 143(2):718-26. PubMed ID: 2472451
[TBL] [Abstract][Full Text] [Related]
7. [Influence of tacrolimus and ciprofloxacin on glucose metabolism].
Tayama Y; Miyake K; Nagafuji T; Gouhara T; Morita S; Arai S; Sato E; Kitaura T; Kihira K
Yakugaku Zasshi; 2007 Nov; 127(11):1883-9. PubMed ID: 17978565
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of whole-blood T lymphocytes in individual patients to tacrolimus (FK 506): impact of interleukin-2 mRNA expression as surrogate measure of immunosuppressive effect.
Härtel C; Schumacher N; Fricke L; Ebel B; Kirchner H; Müller-Steinhardt M
Clin Chem; 2004 Jan; 50(1):141-51. PubMed ID: 14709642
[TBL] [Abstract][Full Text] [Related]
9. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice.
Noguchi H; Matsushita M; Okitsu T; Moriwaki A; Tomizawa K; Kang S; Li ST; Kobayashi N; Matsumoto S; Tanaka K; Tanaka N; Matsui H
Nat Med; 2004 Mar; 10(3):305-9. PubMed ID: 14770176
[TBL] [Abstract][Full Text] [Related]
10. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH
J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice.
Oetjen E; Baun D; Beimesche S; Krause D; Cierny I; Blume R; Dickel C; Wehner S; Knepel W
Mol Pharmacol; 2003 Jun; 63(6):1289-95. PubMed ID: 12761338
[TBL] [Abstract][Full Text] [Related]
12. Cellular signaling mechanisms for stimulation of growth hormone secretion and growth hormone primary transcripts by immunosuppressant agents, FK506 and cyclosporin A, in cultured rat pituitary cells.
Ohye H; Sato M; Murao K; Matsubara S; Tokuda M; Takahara J
Neuroimmunomodulation; 1998; 5(6):309-17. PubMed ID: 9762012
[TBL] [Abstract][Full Text] [Related]
13. [Calcineurin inhibitors and mechanisms that are responsible for the appearance of post-transplant diabetes mellitus].
Ippoliti GB; Viganò M
G Ital Nefrol; 2003; 20 Suppl 25():S11-4. PubMed ID: 14523907
[TBL] [Abstract][Full Text] [Related]
14. Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells.
Triñanes J; Rodriguez-Rodriguez AE; Brito-Casillas Y; Wagner A; De Vries APJ; Cuesto G; Acebes A; Salido E; Torres A; Porrini E
Am J Transplant; 2017 Nov; 17(11):2829-2840. PubMed ID: 28432716
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation.
Ryffel B; Willcocks JL; Brooks N; Woerly G
Immunopharmacology; 1995 Sep; 30(3):199-207. PubMed ID: 8557519
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulus-secretion coupling.
Uchizono Y; Iwase M; Nakamura U; Sasaki N; Goto D; Iida M
Endocrinology; 2004 May; 145(5):2264-72. PubMed ID: 14962991
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo assessment of immunosuppression in undiluted whole blood from pigs dosed with tacrolimus (FK506).
Chen YW; Smith ML; Sheets MP; Ballaron SJ; Trevillyan JM; Fey TA; Gauvin DM; Kolano R; Pong MS; Hsieh GC; Bauch J; Marsh K; Carter G; Luly J; Djuric S; Mollison KW
Clin Immunol; 1999 Jan; 90(1):133-40. PubMed ID: 9884362
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway.
Shibasaki S; Yamashita K; Goto R; Wakayama K; Tsunetoshi Y; Zaitsu M; Igarashi R; Haga S; Ozaki M; Umezawa K; Todo S
Transplantation; 2013 Feb; 95(4):542-50. PubMed ID: 23269193
[TBL] [Abstract][Full Text] [Related]
20. Effect of the immunosuppressive regime of Edmonton protocol on the long-term in vitro insulin secretion from islets of two different species and age categories.
Hyder A; Laue C; Schrezenmeir J
Toxicol In Vitro; 2005 Jun; 19(4):541-6. PubMed ID: 15826812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
